Use of novel antithrombotic agents for COVID-19: Systematic summary of ongoing randomized controlled trials.

Azita H TalasazParham SadeghipourMaryam AghakouchakzadehHessam KakavandHamid AriannejadJean Marie Connors Beverley Jane HuntJeffrey S BergerBenjamin W Van TassellSaskia MiddeldorpGregory PiazzaJeffrey I Weitz Andrea N EdgintonGregory Y H LipSamuel Z GoldhaberBehnood Bikdeli

Published in: Journal of thrombosis and haemostasis : JTH (2021)

Some novel antithrombotic agents have pleiotropic anti-inflammatory and antiviral effects, which may help reduce the viral load or fibrosis, and improve oxygenation. Results from ongoing RCTs will elucidate their actual role in the management of patients with COVID-19.

Keyphrases

anti inflammatory
atrial fibrillation
coronavirus disease
randomized controlled trial
sars cov
systematic review
meta analyses